Balak Salesh 4
4 · UNIVERSAL BIOSENSORS INC · Filed Nov 25, 2019
Insider Transaction Report
Form 4
Balak Salesh
Chief Financial Officier
Transactions
- Exercise/Conversion
Common Stock
2019-11-12+25,000→ 226,558 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-12−25,000→ 0 totalExercise: $0.00Exp: 2019-11-12→ Common Stock (25,000 underlying)
Holdings
- 216,300
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2024-02-27→ Common Stock (216,300 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $0.00Exp: 2020-12-11→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $0.00Exp: 2022-01-29→ Common Stock (40,000 underlying) - 721,000
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2023-04-20→ Common Stock (721,000 underlying)
Footnotes (7)
- [F1]The price reported is stated in Australian dollars.
- [F2]13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vested and became exercisable on 12/31/2017.
- [F3]13,333 stock options vested and became exercisable on 12/31/2014, 13,333 stock options vested and became exercisable on 12/31/2015, and 13,334 stock options vested and became exercisable on 12/31/2016.
- [F4]8,333 stock options vested and became exercisable on 12/31/2013, 8,333 stock options vested and became exercisable on 12/31/2014, and 8,334 stock options vested and became exercisable on 12/31/2015. These options were exercised on 11/12/2019.
- [F5]206,000 of the stock options vested and became exercisable on 10/05/2016, 412,000 of the stock options vested and became exercisable on 12/31/2016 and 103,000 of the stock options vested and became exercisable on 02/23/2017.
- [F6]216,300 stock options vested and became exercisable on 12/31/2017.
- [F7]Includes (i) 219,362 shares in the form of CDIs Mr. Balak holds directly and (ii) 7,196 restricted fully paid shares.